1) Strong Financial Performance
- Fortive reported Q2 2026 consolidated revenue of nearly $1.1 billion, up almost 8% YoY and 6.7% on a core basis.
- Adjusted EBITDA grew 12% YoY to $323 million, with an adjusted EBITDA margin of 29.5%, up 110 basis points YoY.
- Adjusted EPS reached $0.74, marking a 28% increase YoY, continuing a trend of double-digit growth for four consecutive quarters.
- Free cash flow for Q2 was approximately $270 million, contributing to a trailing 12-month free cash flow of over $1 billion.

2) Fortive Accelerated Strategy Execution
- The company is focused on three pillars: driving faster profitable organic growth, disciplined capital allocation, and maintaining investor trust.
- Investments in innovation and customer value are yielding results, with strong demand for new products like CertiFiber Max and AI-enabled solutions.
- Fortive executed a small bolt-on acquisition and repurchased approximately $200 million worth of shares, totaling about 38 million shares or 11% of shares since the launch of New Fortive.
- The full-year adjusted EPS guidance has been raised to $2.95 to $3.05, reflecting confidence in business trajectory.

3) Segment Performance Insights
- Intelligent Operating Solutions (IOS): Revenue grew 9% YoY, with core growth of 7.4%. Strong performance in Professional Instrumentation and facility solutions, particularly in North America and APAC.
- Advanced Healthcare Solutions (AHS): Revenue reached nearly $340 million, up 6% YoY, driven by strong demand for healthcare consumables and software. Adjusted EBITDA was $88 million, up 3% YoY.
- Both segments experienced slight declines in adjusted gross margins due to product mix dynamics and strategic growth investments.

4) Market Challenges and Strategic Outlook
- EMEA revenue declined due to macroeconomic uncertainties, while APAC and LatAm showed strong growth.
- The company is navigating challenges related to hospital capital expenditure budgets, but improvements are noted in capital equipment demand.
- Fortive expects Q3 revenue to be in line with historical patterns, with some headwinds anticipated in Q4 due to fewer selling days.
- The company is focused on maintaining a disciplined approach to capital allocation while pursuing high-quality, accretive bolt-on acquisitions.

5) Missing Information and Conclusion
- The transcript lacks specific details on the impact of macroeconomic factors on future guidance and more granular insights into competitive positioning.
- Bottom line: Fortive's strong Q2 performance and strategic execution reinforce its growth trajectory, with a focus on innovation and disciplined capital allocation positioning the company well for continued shareholder value creation.